ID
20952
Description
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370
Keywords
Versions (1)
- 3/30/17 3/30/17 -
Uploaded on
March 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Survival Follow-up)
Radium 223 Dichloride (Alpharadin) - Survival Follow-up
- StudyEvent: ODM
Description
End of Survival Follow-up
Description
Primary reason for discontinuation
Data type
text
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C1549995
Description
If primary reason is `Other`,specify
Data type
text
Alias
- UMLS CUI [1,1]
- C1549995
- UMLS CUI [1,2]
- C0205394
Description
dd MMM Y.Y.Y.Y
Data type
date
Alias
- UMLS CUI [1,1]
- C1549995
- UMLS CUI [1,2]
- C1148348
Description
Primary cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Other Cause of Death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Similar models
Radium 223 Dichloride (Alpharadin) - Survival Follow-up
- StudyEvent: ODM
C0220825 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C1148348 (UMLS CUI [1,2])
No comments